African Cancer Genome: GMD
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05754658 |
Recruitment Status :
Recruiting
First Posted : March 6, 2023
Last Update Posted : March 27, 2023
|
Sponsor:
Fox Chase Cancer Center
Collaborators:
University of Miami Sylvester Comprehensive Cancer Center
Pfizer
The University of The West Indies, Mona, Jamaica
Kenya Medical Research Institute
University of Nairobi, Kenya
University of Abomey Calavi, Benin
Innovating Health International, Haiti
Institut de Recherche en Sciences de la Sante, Burkina Faso
The University of the West Indies at Cave Hill, Barbados
The University of The West Indies School of Clinical Medicine and Research, The Bahamas
Ministry of Health and Social Services, Namibia
Morgan State University
University of Alabama, Tuscaloosa
Information provided by (Responsible Party):
Camille Ragin, PhD, MPH, Fox Chase Cancer Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | July 1, 2024 |
Estimated Study Completion Date : | July 1, 2024 |